{{Rsnum
|rsid=12900463
|Gene=ALPK3
|Chromosome=15
|position=84872155
|Orientation=plus
|GMAF=0.163
|Gene_s=ALPK3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.4 | 34.8 | 59.8
| HCB | 4.4 | 31.4 | 64.2
| JPT | 1.8 | 22.1 | 76.1
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 8.8 | 91.2
| CHB | 4.4 | 31.4 | 64.2
| CHD | 0.9 | 24.8 | 74.3
| GIH | 0.0 | 27.7 | 72.3
| LWK | 0.0 | 3.6 | 96.4
| MEX | 8.6 | 25.9 | 65.5
| MKK | 0.0 | 8.3 | 91.7
| TSI | 2.9 | 28.4 | 68.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=4E-6
  |OR=2.15
  |ORtxt=[1.342-3.457]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}